Versant Capital Management »

Citius Oncology shares owned by Versant Capital Management

Quarter-by-quarter ownership of Citius Oncology (CTOR) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Citius Oncology

Tip: Access up to 7 years of quarterly data

All positions including Citius Oncology held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Oncology by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5k 1.5k 1.00

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Vaneck Gold Miners Etf Etf (GDX)
Microsoft Stock (MSFT)
Ishares S&p Global Energy Etf (IXC)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)

View all positions for Versant Capital Management

Top funds holding Citius Oncology

Armistice Capital
Vanguard Group
Geode Capital Management
XTX Topco
Renaissance Technologies
State Street Corporation
IFP Advisors
Northern Trust
Citadel Advisors
Tower Research Capital
Advisor Group Holdings
Arkadios Wealth Advisors
Versant Capital Management
UBS Group
Farther Finance Advisors

View all funds holding Citius Oncology